Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BiRD in relapsed/refractory multiple myeloma
NCT02986451Phase 2Withdrawn
- Sponsor
- Sun Yat-sen University
- Start
- Dec 2016
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
A Phase 2 trial of clarithromycin in multiple myeloma (MM), sponsored by Sun Yat-sen University. Planned start Dec 2016; status: withdrawn.
02
Drugs
clarithromycin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02986451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02986451.